Mr Ian Johnston

Experts / Mr Ian Johnston

Environment and science correspondent,Comment editor @thescotsman and @edinburghpaper, interests include environment, politics, history, cycling, guitar, chess

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Cardiology

Podcasts

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

Cardiology

Podcasts

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

By Dr Robert Hungerford

Podcasts

Cardiology

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

By Dr Robert Hungerford

Podcasts

Cardiology

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

By Dr Robert Hungerford

Videos

Cardiology, Drugs and devices

Mr Ian Johnston

More from this expert

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

First Healthed Webcast for 2026

An Update on Heart Failure in Primary Care

Tuesday 3rd February, 7pm - 9pm AEDT

Speaker

Prof Andrew Sindone

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital

We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.

Mr Ian Johnston

More from this expert

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

First Healthed Webcast for 2026

An Update on Heart Failure in Primary Care

Tuesday 3rd February, 7pm - 9pm AEDT

Speaker

Prof Andrew Sindone

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital

We invite you to our first webcast of 2026, where Prof Andrew Sindone will provide an update on heart failure in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.